FDA to modernize drug surveillance internally with use of AI
BALTIMORE — The FDA is modernizing the way it surveils drugs after they come to market, employing new uses for AI with the help of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
